01 1Industriale Chimica SRL
02 1Sicor S.r.l.
01 1Ulipristal Acetate
02 1Ulipristal Acetate (Human)
01 2Italy
NDC Package Code : 63190-0870
Start Marketing Date : 2024-07-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53183-4037
Start Marketing Date : 2013-07-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
A Ulipristal Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ulipristal Acetate, including repackagers and relabelers. The FDA regulates Ulipristal Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ulipristal Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ulipristal Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ulipristal Acetate supplier is an individual or a company that provides Ulipristal Acetate active pharmaceutical ingredient (API) or Ulipristal Acetate finished formulations upon request. The Ulipristal Acetate suppliers may include Ulipristal Acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Ulipristal Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ulipristal Acetate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ulipristal Acetate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ulipristal Acetate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ulipristal Acetate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ulipristal Acetate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ulipristal Acetate suppliers with NDC on PharmaCompass.
We have 2 companies offering Ulipristal Acetate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
